Keyphrases
Transgenic Mice
100%
Huntington's Disease
100%
Somatostatin Receptor
100%
Receptor 1
100%
Double Knockout Mice
100%
Neurochemical Changes
100%
Somatostatin
50%
SSTR1
50%
Neurotoxicity
37%
Pathophysiology
25%
Signaling Molecules
25%
Medium Size
25%
Dopamine- and cAMP-regulated Phosphoprotein of 32 kDa
25%
Somatostatin Receptor Subtypes
25%
Molecular Mechanism
12%
Neurodegeneration
12%
N-methyl-D-aspartate Receptor (NMDAR)
12%
Inducible Nitric Oxide Synthase
12%
Striatal
12%
Striatum
12%
G Protein-coupled Receptor
12%
Enkephalin
12%
Protein Kinase
12%
Ablation
12%
Calcineurin
12%
Phosphoinositide 3-kinase (PI3K)
12%
Transgenic Mouse Model
12%
Calpain
12%
Projection Neurons
12%
Disease-related
12%
Vulnerability
12%
Biological Response
12%
Biological Effects
12%
Receptor Subtypes
12%
Mouse Brain
12%
Medium Spiny Neurons
12%
Acid Activation
12%
N-methyl-D-aspartic Acid Receptor
12%
N-methyl-D-aspartic Acid
12%
Receptor Gene
12%
Neuroprotective Role
12%
Significant Loss
12%
Strain Specificity
12%
Extracellular Signaling
12%
Interneuron
12%
Calbindin
12%
Synapsin
12%
Subtype Selectivity
12%
Caudate-putamen
12%
Pathological Characteristics
12%
Quinolinic Acid
12%
Somatostatin Neurons
12%
Neuroscience
Somatostatin Receptor 1
100%
Huntington's Disease
100%
Somatostatin Receptor 5
100%
Somatostatin
62%
Receptor Subtype
37%
Excitotoxicity
37%
Cyclic Adenosine Monophosphate
25%
N-Methyl-D-Aspartic Acid
25%
Somatostatin Receptor
25%
Phosphoprotein
25%
Nitric Oxide Synthase
12%
Neurodegeneration
12%
Striatum
12%
G Protein Coupled Receptor
12%
Calcineurin
12%
Receptor Gene
12%
Neuroprotective Agent
12%
Medium Spiny Neuron
12%
Phosphoinositide 3-Kinase
12%
Protein Kinase C
12%
Calpain
12%
Calbindin
12%
Synapsin
12%
Enkephalin
12%
Putamen
12%
Quinolinic Acid
12%
Interneuron
12%
Mouse Brain
12%